Skip to main content
GutCited

Vitamin D Irritable Bowel Syndrome (IBS)

C

Limited studies suggest vitamin D supplementation may improve IBS symptoms, particularly in deficient individuals. Mechanism via VDR-mediated immune modulation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

結論

Limited studies suggest vitamin D supplementation may improve IBS symptoms, particularly in deficient individuals. Mechanism via VDR-mediated immune modulation.

Key Study Findings

Review
Early Evidence Indicates Vitamin D Improves Symptoms of Irritable Bowel Syndrome: Nursing Implications and Future …
Dose: None vs: None Outcome: IBS symptom improvement with vitamin D supplementation 効果: None None

対象集団: individuals with irritable bowel syndrome

Systematic Review
Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews …
Dose: None vs: Various Outcome: IBS symptom improvement 効果: Probiotics abdominal pain RR 4.04 (2.36-6.92) None

対象集団: Adult IBS patients

Meta-Analysis Double-blind
The effects of vitamin D intake and status on symptom severity and quality-of-life in adults …
Dose: 3,000 IU daily to 50,000 IU bi-weekly vs: Placebo Outcome: IBS symptom severity and quality of life 効果: MD 20.33 ng/mL [12.91, 27.74] for 25(OH)D; QoL 3.1 None

対象集団: Adults with IBS and deficient/insufficient vitamin D

Review
Modifiable risk factors associated with the risk of developing Parkinson's disease: a critical review.
Dose: None vs: None Outcome: Risk of developing Parkinson's disease 効果: None None

対象集団: General population (narrative review of PD risk factors)

Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None vs: None Outcome: Micronutrient deficiency management in pediatric IBD 効果: None None

対象集団: Children with inflammatory bowel disease (review)

Review
Vitamin D in Irritable Bowel Syndrome: Exploring Its Role in Symptom Relief and Pathophysiology.
Dose: None vs: None Outcome: IBS symptom relief and pathophysiology modulation 効果: None None

対象集団: Patients with irritable bowel syndrome (review)

Key Statistics

3

研究数

400

参加者数

Positive

C

グレード

Referenced Papers

Scandinavian journal of … 2025
Journal of gastroenterology … 2023 16 件の引用
World journal of … 2023 9 件の引用
Journal of gastroenterology … 2022 30 件の引用
Journal of gastroenterology … 2022 29 件の引用
The journal of … 2020 294 件の引用
Current gastroenterology reports 2017 157 件の引用
World journal of … 2016 238 件の引用
Clinics in dermatology 2016 19 件の引用
World journal of … 2015 62 件の引用
European journal of … 2012 225 件の引用
Inflammatory bowel diseases 2012 224 件の引用
The Cochrane database … 2012 130 件の引用
Current opinion in … 2011 23 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
600-800 IU/day (RDA)
ibdsupport:
1,000-4,000 IU/day (target serum 25(OH)D >30 ng/mL)
deficiencycorrection:
50,000 IU/week for 8 weeks, then 1,000-4,000 IU/day maintenance

上限量: 4,000 IU/day (100 mcg); higher doses under medical supervision only

研究で検討された用量

用量 期間 効果 N
None -- Positive --
None -- Positive --
3,000 IU daily to 50,000 IU bi-weekly -- Positive --
None -- Mixed --
None -- Neutral --
None -- Positive --
None -- Positive --
None -- Positive 240

推奨摂取タイミング: With a meal containing fat for better absorption

Safety & Side Effects

報告されている副作用

  • Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion)
  • Kidney stones with excessive long-term supplementation
  • Constipation
  • Metallic taste

既知の相互作用

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

耐容上限摂取量: 4,000 IU/day (100 mcg); higher doses under medical supervision only

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Vitamin D help with Irritable Bowel Syndrome (IBS)?
Based on 3 studies with 400 participants, there is limited but promising evidence that Vitamin D may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is C (Some Evidence).
How much Vitamin D should I take for Irritable Bowel Syndrome (IBS)?
Studies have used various dosages. A commonly studied range is 600-800 IU/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness, confusion), Kidney stones with excessive long-term supplementation, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Irritable Bowel Syndrome (IBS)?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 400 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。